CERULEAN SCIENTIFIC INC

Cerulean Scientific is a Durham, North Carolina-based medical device company developing implantable and indwelling devices resistant to thrombus formation, clogging, and failure through its proprietary Cerulean Surface Technology (CST). CST has demonstrated up to 97% reduction in thrombus accumulation in hemodialysis catheters in vitro, with the company targeting partnerships with medical device manufacturers to integrate CST into vascular access and other catheter platforms. The company aims to reduce healthcare costs and improve patient safety by extending the longevity of critical medical devices.